Friday, December 04, 2015 11:13:32 AM
KBIO / Turing:
Why acquire the drug via KBIO and not Turing?
I heard the (short) call and in the remarks Martin (also slide 25) said about exploring possible deal with Turing though no assurance of consummating one. I imagine a (reverse) merger is still on the table.
While they opened the call for Q&A there were no questions on the call. Its only about 10 minutes (less the opening disclaimer) but seems to be script from the slide deck so you can look at that or listen
.
http://ir.kalobios.com/eventdetail.cfm?EventID=167900
Why acquire the drug via KBIO and not Turing?
I heard the (short) call and in the remarks Martin (also slide 25) said about exploring possible deal with Turing though no assurance of consummating one. I imagine a (reverse) merger is still on the table.
While they opened the call for Q&A there were no questions on the call. Its only about 10 minutes (less the opening disclaimer) but seems to be script from the slide deck so you can look at that or listen
. http://ir.kalobios.com/eventdetail.cfm?EventID=167900
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
